Jinbao Liu

1PUBLICATIONS
1CO-AUTHORS
Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 23, 2022
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.

Leyi Yao, Qian Zhao, Ding Yan

Pageof 1

Frequent Collaborators

1 joint publications

Xin Chen